Clinical Trials Logo

Lung Neoplasm clinical trials

View clinical trials related to Lung Neoplasm.

Filter by:

NCT ID: NCT03634826 Recruiting - Lung Cancer Clinical Trials

Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer).

MEDAL
Start date: August 15, 2018
Phase:
Study type: Observational

Conduct a prospective study to confirm the value of circulating tumor DNA and its aberrant methylation in longitudinal monitoring of surgical lung cancer patients.

NCT ID: NCT03523689 Completed - Lung Neoplasm Clinical Trials

Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy

Start date: April 30, 2018
Phase:
Study type: Observational

This trial studies how well radial-probe endobronchial ultrasound works in detecting the complete or partial collapse of the lung in patients undergoing peripheral bronchoscopy. Diagnostic procedures, such as radial-probe endobronchial ultrasound and bronchoscopy, use a thin, tube-like instrument inserted through the nose or mouth to view and take pictures of the inside of the trachea, air passages, and lungs.

NCT ID: NCT03516500 Completed - Lung Neoplasm Clinical Trials

Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining

Start date: May 9, 2018
Phase: N/A
Study type: Interventional

This is a protocol to determine the safety and feasibility of using Iron Sucrose Injection to identify the intersegmental plane,not only on the pleural surface but also the parenchyma of the lung.

NCT ID: NCT03368820 Recruiting - Lung Neoplasm Clinical Trials

Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry

Start date: December 4, 2017
Phase:
Study type: Observational [Patient Registry]

Therapeutic algorithms for lung cancer are mainly based on randomised controlled trials which excluded patients with severe co-morbidities. Smoking, the main risk factor for lung cancer, is associated with cardiovascular events that may impact on the therapeutic decision. The aim of this registry is to determine if and how cardiovascular co-morbidities impact on the physicians' decision for anticancer treatment in lung cancer patients by comparing it to the European Lung Cancer Working Party (ELCWP) guidelines

NCT ID: NCT03320044 Completed - Carcinoma Clinical Trials

Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing

Start date: October 18, 2017
Phase:
Study type: Observational

Analyse immune repertoire and genetic mutations of benign and malignant pulmonary noduleļ¼Œand evaluate peripheral blood detection for identifying nature of pulmonary nodule.

NCT ID: NCT03301961 Recruiting - Carcinoma Clinical Trials

Multiplex Analysis of Circulating Tumor DNA

Start date: April 11, 2019
Phase:
Study type: Observational

Lung cancer is the leading cause of cancer-related death in China. This study will explore the applications of multiplex analysis of circulating tumor DNA biomarkers for diagnosis and surveillance of lung cancer patients

NCT ID: NCT03134729 Completed - Pain, Postoperative Clinical Trials

PATHOS Study Pain Assessment in Thoracic Oncologic Surgery

PATHOS
Start date: May 4, 2017
Phase: N/A
Study type: Interventional

A randomized prospective trial to assess whether the use of loco regional anesthesia as adjuvant analgesic therapy is more effective of intravenous analgesia only.

NCT ID: NCT03090880 Terminated - Clinical trials for Venous Thromboembolism

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)

PROVE
Start date: September 14, 2018
Phase: Phase 3
Study type: Interventional

Prospective randomized open multicenter trial with blinded adjudication of endpoints to assess the efficacy of six-month low-dose LMWH (Low Molecular Weight Heparin) for the prevention of symptomatic or incidental VTE in patients with stage IV lung cancer and elevated D-dimer.

NCT ID: NCT03070626 Recruiting - Lung Neoplasm Clinical Trials

Preoperative Loading With Carbohydrates in Lung Cancer Surgery

Start date: March 20, 2017
Phase: N/A
Study type: Interventional

Administration of preoperative oral carbohydrates are suggested to reduce insulin resistance due to surgical stress. The aim of this study is to investigate whether preoperative oral carbohydrate loading can contribute to lower incidence of postoperative discomfort and to reduce complications in elective lung cancer patients undergoing video assisted thorascopic surgery (VATS).

NCT ID: NCT03037385 Completed - Neoplasms Clinical Trials

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

ARROW
Start date: March 17, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase 1/2, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary antineoplastic activity of pralsetinib (BLU-667) administered orally in participants with medullary thyroid cancer (MTC), RET-altered NSCLC and other RET-altered solid tumors.